3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 26.20
+0.30 (1.16%)
Nov 13, 2026, 1:55 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 2.02 billion as of November 13, 2026. It is the 28,439th most valuable company in the world and the 1,626th biggest in Taiwan. Its market cap has decreased by 43.79% in one year.
Market Cap
2.02B
Enterprise Value
1.56B
Revenue
159.19M
Global Rank
Country Rank
#1,626 Taiwan
PE Ratio
142.53
ChartMarket Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has decreased from 2.74B to 2.02B, a decrease of -26.29%. That is a compound annual growth rate of -5.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 2.02B | -46.35% |
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intech Biopharm | 2.74B |
| Senhwa Biosciences | 2.65B |
| Energenesis Biomedical CO.,LTD. | 2.64B |
| Chunghwa Chemical Synthesis & Biotech | 2.38B |
| GlycoNex Incorporation | 2.28B |
| Syngen Biotech | 2.18B |
| Taiwan Bio Therapeutics | 2.17B |
| HeXun Biosciences | 2.09B |